Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo
- PMID: 8328782
- PMCID: PMC187961
- DOI: 10.1128/AAC.37.6.1329
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo
Abstract
Clarithromycin provided effective therapy against arthritis induced by Borrelia burgdorferi infection in the hamster. In vitro, clarithromycin was at least 1 log more potent than tetracycline against two isolates of B. burgdorferi from human sources, as measured by MICs and 50% inhibitory concentrations. Clarithromycin was effective in preventing the onset of B. burgdorferi-induced arthritis, as determined by several parameters of paw swelling. When administered after the onset of arthritis, clarithromycin therapy reduced the degree of swelling and decreased recovery time. These results suggest that clarithromycin has potential as an effective therapy for Lyme disease.
Similar articles
-
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.Antimicrob Agents Chemother. 1990 Nov;34(11):2133-6. doi: 10.1128/AAC.34.11.2133. Antimicrob Agents Chemother. 1990. PMID: 2073103 Free PMC article.
-
Experimental Borrelia burgdorferi infection of outbred mice.J Clin Microbiol. 1992 Nov;30(11):3016-8. doi: 10.1128/jcm.30.11.3016-3018.1992. J Clin Microbiol. 1992. PMID: 1452675 Free PMC article.
-
[Comment on Borrelia burgdorferi Group infections].Orv Hetil. 2002 May 26;143(21):1223-4. Orv Hetil. 2002. PMID: 12073543 Hungarian. No abstract available.
-
[Suspected Lyme borreliosis: how to diagnose, whom to treat?].Ther Umsch. 1992 Apr;49(4):257-62. Ther Umsch. 1992. PMID: 1615461 Review. German.
-
Studies on the pathogenesis and treatment of Lyme arthritis.Wien Klin Wochenschr. 1999 Dec 10;111(22-23):981-4. Wien Klin Wochenschr. 1999. PMID: 10666814 Review.
Cited by
-
Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview.Transl Neurodegener. 2023 Jul 26;12(1):37. doi: 10.1186/s40035-023-00369-7. Transl Neurodegener. 2023. PMID: 37496074 Free PMC article. Review.
-
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.Wien Klin Wochenschr. 2006 Nov;118(21-22):659-68. doi: 10.1007/s00508-006-0693-z. Wien Klin Wochenschr. 2006. PMID: 17160604 Review.
-
Clarithromycin in treatment of early Lyme disease: a pilot study.Antimicrob Agents Chemother. 1996 Feb;40(2):468-9. doi: 10.1128/AAC.40.2.468. Antimicrob Agents Chemother. 1996. PMID: 8834900 Free PMC article.
-
Choosing the right macrolide antibiotic. A guide to selection.Drugs. 1997 Mar;53(3):349-57. doi: 10.2165/00003495-199753030-00002. Drugs. 1997. PMID: 9074839 Review.
-
The In Vitro Antimicrobial Susceptibility of Borrelia burgdorferi sensu lato: Shedding Light on the Known Unknowns.Pathogens. 2023 Sep 28;12(10):1204. doi: 10.3390/pathogens12101204. Pathogens. 2023. PMID: 37887720 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical